| Synthesis and SAR studies of mono O-prenylated coumarins as potent 15-lipoxygenase inhibitors M Iranshahi, A Jabbari, A Orafaie, R Mehri, S Zeraatkar, T Ahmadi, ... European journal of medicinal chemistry 57, 134-142, 2012 | 59 | 2012 |
| Synthesis of imidazo[4,5-a]acridones and imidazo[4,5-a]acridines as potential antibacterial agents M Rahimizadeh, M Pordel, M Bakavoli, Z Bakhtiarpoor, A Orafaie Monatshefte für Chemie-Chemical Monthly 140, 633-638, 2009 | 57 | 2009 |
| The importance of 15-lipoxygenase inhibitors in cancer treatment A Orafaie, MM Matin, H Sadeghian Cancer and Metastasis Reviews 37, 397-408, 2018 | 52 | 2018 |
| An overview of lipoxygenase inhibitors with approach of in vivo studies A Orafaie, M Mousavian, H Orafai, H Sadeghian Prostaglandins & Other Lipid Mediators 148, 106411, 2020 | 34 | 2020 |
| Design, synthesis, and structure–activity relationship study of 5-amido-1-(2,4-dinitrophenyl)-1H-4-pyrazolecarbonitrils as DD-carboxypeptidase/penicillin-binding … H Sadeghian, A Sadeghian, M Pordel, M Rahimizadeh, P Jahandari, ... Medicinal chemistry research 19, 103-119, 2010 | 18 | 2010 |
| Use of anticancer peptides as an alternative approach for targeted therapy in breast cancer: a review A Orafaie, AR Bahrami, MM Matin Nanomedicine 16 (5), 415-433, 2021 | 15 | 2021 |
| 7-farnesyloxycoumarin exerts anti-cancer effects on a prostate cancer cell line by 15-LOX-1 inhibition S Saboormaleki, H Sadeghian, AR Bahrami, A Orafaie, MM Matin Archives of Iranian Medicine 21 (6), 251-259, 2018 | 13 | 2018 |
| 5-farnesyloxycoumarin: a potent 15-LOX-1 inhibitor, prevents prostate cancer cell growth A Orafaie, H Sadeghian, AR Bahrami, S Saboormaleki, MM Matin Medicinal Chemistry Research 26, 227-234, 2017 | 9 | 2017 |
| Design, synthesis and evaluation of PD-L1 peptide antagonists as new anticancer agents for immunotherapy A Orafaie, H Sadeghian, AR Bahrami, H Rafatpanah, MM Matin Bioorganic & Medicinal Chemistry 30, 115951, 2021 | 8 | 2021 |
| Laparoscopic surgery for rectal cancer, specimen extraction: transanal or transabdominal? F Shahabi, A Orafaie, M Ansari, ZG Moallem, A Mehri, MH Moghadam, ... BMC surgery 23 (1), 163, 2023 | 1 | 2023 |
| Significant Pathologic Response Following Neoadjuvant Therapy and Curative Resection in Patients With Rectal Cancer: Surgical and Oncological Outcomes From a Retrospective … F Shahabi, M Ansari, K Najafi Ghobadi, A Ghahramani, A Parandeh, ... Cancer Reports 7 (11), e70041, 2024 | | 2024 |
| Post recurrence survival in early versus late period and its prognostic factors in rectal cancer patients F Shahabi, A Mehri, A Abdollahi, SHH Hoshyar, A Ghahramani, MG Noei, ... Scientific Reports 14 (1), 17661, 2024 | | 2024 |
| The association of preoperative hematologic parameters with short‐term clinical outcomes in rectal cancer: A feature importance analysis A Orafaie, F Shahabi, A Mehri, M Ansari, S Kasraeifar, M Ghiyasi, ... Cancer Medicine 13 (10), e7225, 2024 | | 2024 |
| The Role of Re-laparoscopy in the Management of Complications Following Laparoscopic Rectal Cancer Surgery: A Retrospective Case Series A Attaran, F Shahabi, A Orafaie, M Ansari, R Rezaei, A Abdollahi Iranian Journal of Colorectal Research 11 (4), 128-133, 2023 | | 2023 |
Fatemeh ShahabiEndoscopic and Minimally Invasive Surgery research center, Mashhad University of Medical Sciences在 mums.ac.ir 的电子邮件经过验证
